How does Yokogawa support its customers?
Ypsomed generates its revenue primarily by developing, manufacturing, and supplying innovative injection and infusion systems for self-administration, catering to pharmaceutical companies and diabetes patients worldwide. Its core business model centers on two primary divisions: the development of proprietary drug delivery devices—such as reusable and disposable pen injectors, auto-injectors, and patch pumps—sold under business-to-business supply agreements to major pharmaceutical firms packaging biologic drugs, and its direct-to-consumer diabetes care business supplying blood glucose meters and infusion sets. Ypsomed makes money by securing upfront device development contracts, milestone payments, and high-volume commercial manufacturing agreements where pharmaceutical partners purchase customized injection pens in bulk. This business-to-business medical device manufacturing model provides resilient recurring revenue streams backed by long-term clinical drug delivery contracts.
Related FAQs
York Space Systems LLC is a prominent American aerospace company specializing in the design, manufacturing, and operation of standardized spacecraft platforms, mission management software, and complete end-to-end satellite solutions for defense an...